In vivo evaluation of small-molecule thermoresponsive anticancer drugs potentiated by hyperthermia |
| |
| Authors: | Catherine M Clavel Patrycja Nowak-Sliwinska Emilia P?unescu Arjan W Griffioen Paul J Dyson |
| |
| Institution: | a Institut des Sciences et Ingénierie Chimiques , Ecole Polytechnique Fédérale de Lausanne (EPFL) , CH-1015 Lausanne , Switzerland . Email: ; Fax: +41 21 693 97 80 ; Tel: +41 21 693 98 54 |
| |
| Abstract: | Hyperthermia used as an adjuvant with chemotherapy is highly promising in the treatment of certain cancers. Currently, the small molecule drugs used in combination with hyperthermia were not designed for this application. Herein, we report the evaluation of a chlorambucil and a ruthenium compound modified with a long fluorous chain, which exhibit thermoresponsive activity in colorectal adenocarcinoma xenografts in athymic mice in combination with mild hyperthermia (42 °C). Intraperitoneal injection of the derivatives followed by local hyperthermia showed a synergistic tumor growth reduction by 79% and 90% for the chlorambucil and ruthenium-based derivatives, respectively, with the latter exhibiting a higher synergy in combination with hyperthermia compared to the monotherapies. Histological analysis shows that both derivatives in combination with hyperthermia significantly decrease the number of proliferating tumor cells. |
| |
| Keywords: | |
|
|
